World Journal of Cardiovascular Diseases

Volume 15, Issue 5 (May 2025)

ISSN Print: 2164-5329   ISSN Online: 2164-5337

Google-based Impact Factor: 0.32  Citations  

Diagnosis and Management of Cardiac Amyloidosis: The Role of Multimodal Imaging—A Mini Review

  XML Download Download as PDF (Size: 1268KB)  PP. 235-253  
DOI: 10.4236/wjcd.2025.155021    40 Downloads   243 Views  

ABSTRACT

Cardiac amyloidosis is a disease characterized by the deposition of misfolded proteins in the myocardium, leading to restrictive cardiomyopathy. It comprises two subtypes: immunoglobulin light chain cardiac amyloidosis (AL) and transthyretin cardiac amyloidosis (ATTR). ATTR is classified as wild-type (wtATTR) and hereditary (hATTR), depending on the presence or absence of a transthyretin (TTR) genetic mutation. The diagnosis of cardiac amyloidosis is challenging due to nonspecific symptoms with other cardiac conditions, often resulting in misdiagnosis. This mini review provides an in-depth analysis of cardiac amyloidosis, focusing on its subtypes, clinical manifestations, diagnostic multimodal imaging, and recent therapeutic advancements.

Share and Cite:

Ponce-Acosta, C. , Santa-Ana-Bayona, M. , Acosta-Gutiérrez, G. , Martinez-Dominguez, P. , Luna-Alcala, S. , Gonzalez-Trejo, A. , Valencia-Hernandez, H. , Guerra, E. and Espinola-Zavaleta, N. (2025) Diagnosis and Management of Cardiac Amyloidosis: The Role of Multimodal Imaging—A Mini Review. World Journal of Cardiovascular Diseases, 15, 235-253. doi: 10.4236/wjcd.2025.155021.

Cited by

No relevant information.

Copyright © 2025 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.